Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells.

Polito VA, Cristantielli R, Weber G, Del Bufalo F, Belardinilli T, Arnone CM, Petretto A, Antonucci L, Giorda E, Tumino N, Pitisci A, De Angelis B, Quintarelli C, Locatelli F, Caruana I.

Front Immunol. 2019 Nov 22;10:2717. doi: 10.3389/fimmu.2019.02717. eCollection 2019.

2.

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia.

Quintarelli C, Sivori S, Caruso S, Carlomagno S, Falco M, Boffa I, Orlando D, Guercio M, Abbaszadeh Z, Sinibaldi M, Di Cecca S, Camera A, Cembrola B, Pitisci A, Andreani M, Vinti L, Gattari S, Del Bufalo F, Algeri M, Li Pira G, Moseley A, De Angelis B, Moretta L, Locatelli F.

Leukemia. 2019 Nov 19. doi: 10.1038/s41375-019-0613-7. [Epub ahead of print]

PMID:
31745215
3.

PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation.

Tumino N, Besi F, Di Pace AL, Mariotti FR, Merli P, Li Pira G, Galaverna F, Pitisci A, Ingegnere T, Pelosi A, Quatrini L, Munari E, Locatelli F, Moretta L, Vacca P.

Leukemia. 2019 Oct 4. doi: 10.1038/s41375-019-0585-7. [Epub ahead of print] No abstract available.

PMID:
31586150
4.

Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation.

Merli P, Caruana I, De Vito R, Strocchio L, Weber G, Bufalo FD, Buatois V, Montanari P, Cefalo MG, Pitisci A, Algeri M, Galaverna F, Quintarelli C, Cirillo V, Pagliara D, Ferlin W, Ballabio M, De Min C, Locatelli F.

Haematologica. 2019 Nov;104(11):2314-2323. doi: 10.3324/haematol.2019.216101. Epub 2019 Feb 21.

5.

Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia.

Folgiero V, Sorino C, Pallocca M, De Nicola F, Goeman F, Bertaina V, Strocchio L, Romania P, Pitisci A, Iezzi S, Catena V, Bruno T, Strimpakos G, Passananti C, Mattei E, Blandino G, Locatelli F, Fanciulli M.

EMBO Rep. 2018 Mar;19(3). pii: e44871. doi: 10.15252/embr.201744871. Epub 2018 Jan 24.

6.

Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome.

Starc N, Li M, Algeri M, Conforti A, Tomao L, Pitisci A, Emma F, Montini G, Messa P, Locatelli F, Bernardo ME, Vivarelli M.

Cytotherapy. 2018 Mar;20(3):322-334. doi: 10.1016/j.jcyt.2017.12.001. Epub 2017 Dec 29.

PMID:
29291917
7.

Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency.

Starc N, Ingo D, Conforti A, Rossella V, Tomao L, Pitisci A, De Mattia F, Brigida I, Algeri M, Montanari M, Palumbo G, Merli P, Rossi P, Aiuti A, Locatelli F, Bernardo ME.

Sci Rep. 2017 Aug 15;7(1):8153. doi: 10.1038/s41598-017-08550-5.

8.

Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients.

Leoncini PP, Vitullo P, Di Florio F, Tocco V, Cefalo MG, Pitisci A, Girardi K, Niemeyer C, Locatelli F, Bertaina A.

Br J Haematol. 2018 Sep;182(6):909-912. doi: 10.1111/bjh.14876. Epub 2017 Aug 2. No abstract available.

PMID:
28771681
9.

T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders.

Bertaina A, Pitisci A, Sinibaldi M, Algeri M.

Curr Hematol Malig Rep. 2017 Feb;12(1):68-78. doi: 10.1007/s11899-017-0364-3. Review.

PMID:
28116633
10.

Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress.

Conforti A, Starc N, Biagini S, Tomao L, Pitisci A, Algeri M, Sirleto P, Novelli A, Grisendi G, Candini O, Carella C, Dominici M, Locatelli F, Bernardo ME.

Oncotarget. 2016 Nov 22;7(47):77416-77429. doi: 10.18632/oncotarget.12678.

11.

The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF.

Moretta F, Petronelli F, Lucarelli B, Pitisci A, Bertaina A, Locatelli F, Mingari MC, Moretta L, Montaldo E.

Eur J Immunol. 2016 May;46(5):1271-8. doi: 10.1002/eji.201546079. Epub 2016 Feb 19.

12.

Mesenchymal stromal cells and chronic inflammatory bowel disease.

Algeri M, Conforti A, Pitisci A, Starc N, Tomao L, Bernardo ME, Locatelli F.

Immunol Lett. 2015 Dec;168(2):191-200. doi: 10.1016/j.imlet.2015.06.018. Epub 2015 Jul 10. Review.

PMID:
26170204
13.

Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient.

Conforti A, Taranta A, Biagini S, Starc N, Pitisci A, Bellomo F, Cirillo V, Locatelli F, Bernardo ME, Emma F.

J Transl Med. 2015 May 7;13:143. doi: 10.1186/s12967-015-0494-0.

14.

Erythropoietic protoporphyria in a boy.

Buonuomo PS, Macchiaiolo M, Gonfiantini MV, Biolcati G, Pitisci A, Villani A, Bartuli A.

Arch Dis Child. 2015 Jan;100(1):7. doi: 10.1136/archdischild-2014-307082. Epub 2014 Nov 12. No abstract available.

PMID:
25392202
15.

Pyridinyl imidazole compounds interfere with melanosomes sorting through the inhibition of cyclin G-associated Kinase, a regulator of cathepsins maturation.

Bellei B, Pitisci A, Migliano E, Cardinali G, Picardo M.

Cell Signal. 2014 Apr;26(4):716-23. doi: 10.1016/j.cellsig.2013.12.023. Epub 2014 Jan 8.

PMID:
24412755
16.

Vitiligo: a possible model of degenerative diseases.

Bellei B, Pitisci A, Ottaviani M, Ludovici M, Cota C, Luzi F, Dell'Anna ML, Picardo M.

PLoS One. 2013;8(3):e59782. doi: 10.1371/journal.pone.0059782. Epub 2013 Mar 26.

17.

Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathway.

Bellei B, Pitisci A, Izzo E, Picardo M.

PLoS One. 2012;7(3):e33021. doi: 10.1371/journal.pone.0033021. Epub 2012 Mar 13.

18.

Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.

Bellei B, Pitisci A, Catricalà C, Larue L, Picardo M.

Pigment Cell Melanoma Res. 2011 Apr;24(2):309-25. doi: 10.1111/j.1755-148X.2010.00800.x. Epub 2011 Jan 11.

PMID:
21040502
19.

p38 regulates pigmentation via proteasomal degradation of tyrosinase.

Bellei B, Maresca V, Flori E, Pitisci A, Larue L, Picardo M.

J Biol Chem. 2010 Mar 5;285(10):7288-99. doi: 10.1074/jbc.M109.070573. Epub 2010 Jan 6.

20.

Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis.

Ceci M, Gallo P, Santonastasi M, Grimaldi S, Latronico MV, Pitisci A, Missol-Kolka E, Scimia MC, Catalucci D, Hilfiker-Kleiner D, Condorelli G.

Cell Death Differ. 2007 May;14(5):1060-2. Epub 2007 Jan 19. No abstract available.

Supplemental Content

Loading ...
Support Center